Skip to main content
. 2012 Dec 1;13(14):1355–1373. doi: 10.4161/cbt.22020

graphic file with name cbt-13-1355-g2.jpg

Figure 2. Folate transporters, folate metabolic pathways and intracellular enzyme targets of antifolates. Folate and antifolate transport across biological membranes is mediated by the reduced folate carrier (RFC), the proton-coupled folate transporter (PCFT) and folate receptors (FR). While RFC and PCFT are facilitative transporters, FRs mediate transport by a non-classical endocytosis involving formation of endosomes that migrate to the cytoplasm. Exit of the folate ligand from the endosome involves diffusion or a mediated process. PCFT has been proposed to facilitate endosomal exit,38 however this does not appear to be obligatory.16 Intracellular folates including tetrahydrofolate (THF), dihydrofolate (DHF), 10-formyl tetrahydrofolate (10-CHO-THF), 5, 10-methylene tetrahydrofolate (5,10-CH2-THF), 5,10-methenyl tetrahydrofolate (5,10-CH+-THF), and 5-methyl tetrahydrofolate (5-CH3-THF) participate in folate interconverting and biosynthetic reactions. Reactions 1–4 are in both the cytoplasmic and mitochodrial compartments. Reactions 1 and 9 are also present in the nucleus. Reaction 1 designates serine hydroxymethyltransferase. In the mitochondria, reactions 2 and 3 are catalyzed by bifunctional 5,10-CH2-THF dehydrogenase (MTHFD) 2 or MTHFD2L and 4 is catalyzed by monofunctional MTHFD1L. In the cytoplasm, reactions 4, 3 and 2 are catalyzed by the 10-CHO-THF synthetase, 5,10-CH+-THF cyclohydrolase and MTFD activities, respectively, of the trifunctional C1-THF synthase (MTHFD1). Other steps shown are catalyzed by β-glycinamide ribonucleotide formyltransferase (GARFTase; reaction 5), 5-amino-4-imidazolecarboxamide ribonucleotide formyltransferase (AICARFTase; reaction 6), thymidylate synthase (TS; reaction 7), dihydrofolate reductase (DHFR; reaction 8), 5,10-methyleneTHF reductase (MTHFR; reaction 9), and methionine synthase (MS; reaction 10). Antifolates inhibit folate biosynthetic reactions as shown and include aminopterin (AMT), methotrexate (MTX), pralatrexate (PDX), raltitrexed (RTX), lometrexol (LMX), pemetrexed (PMX), ONX-0801 (ONX), and compounds 3, 16 and 17.